Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer

Update Il y a 4 ans
Reference: NCT00320385

Woman Man

Extract

This study will evaluate and compare the safety and efficacy of lapatinib in combination with trastuzumab versus lapatinib monotherapy in subjects with HER2-positive metastatic breast cancer.


Inclusion criteria

  • Neoplasms, Breast


Links